CINECA IRIS Institutional Research Information System

LAZZARATO, Loretta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.550
EU - Europa 3.385
AS - Asia 1.382
SA - Sud America 39
AF - Africa 30
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 9
Totale 10.414
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.476
CN - Cina 836
IT - Italia 793
DE - Germania 563
IE - Irlanda 445
SE - Svezia 318
UA - Ucraina 229
FR - Francia 179
FI - Finlandia 171
AT - Austria 161
PL - Polonia 140
GB - Regno Unito 139
DK - Danimarca 132
SG - Singapore 132
KR - Corea 113
VN - Vietnam 77
CA - Canada 66
IN - India 59
JP - Giappone 53
BR - Brasile 24
TR - Turchia 24
RU - Federazione Russa 21
HK - Hong Kong 20
NL - Olanda 18
BE - Belgio 17
CH - Svizzera 15
SN - Senegal 15
AU - Australia 14
TW - Taiwan 11
UZ - Uzbekistan 10
EG - Egitto 9
ES - Italia 9
IR - Iran 8
MX - Messico 8
EU - Europa 7
JO - Giordania 7
SK - Slovacchia (Repubblica Slovacca) 6
AE - Emirati Arabi Uniti 5
CZ - Repubblica Ceca 5
GR - Grecia 5
TH - Thailandia 5
CL - Cile 4
ID - Indonesia 4
IQ - Iraq 4
NZ - Nuova Zelanda 4
PT - Portogallo 4
AR - Argentina 3
BG - Bulgaria 3
EC - Ecuador 3
HR - Croazia 3
PE - Perù 3
RO - Romania 3
AF - Afghanistan, Repubblica islamica di 2
AM - Armenia 2
BQ - ???statistics.table.value.countryCode.BQ??? 2
DZ - Algeria 2
HU - Ungheria 2
MY - Malesia 2
NO - Norvegia 2
PK - Pakistan 2
UY - Uruguay 2
ZA - Sudafrica 2
CI - Costa d'Avorio 1
CY - Cipro 1
IL - Israele 1
LU - Lussemburgo 1
MO - Macao, regione amministrativa speciale della Cina 1
MU - Mauritius 1
PH - Filippine 1
PW - Palau 1
RS - Serbia 1
SA - Arabia Saudita 1
SY - Repubblica araba siriana 1
Totale 10.414
Salva come PNG Salva come JPEG
Città #
Ann Arbor 698
Chandler 609
Fairfield 541
Dublin 440
Beijing 422
Ashburn 378
Woodbridge 268
Torino 252
Houston 244
Seattle 209
Wilmington 209
Cambridge 169
Jacksonville 166
Vienna 159
Frankfurt am Main 158
Pisa 146
Dearborn 136
Warsaw 131
Nyköping 126
Medford 108
Princeton 104
Villeurbanne 104
Redwood City 77
Singapore 72
Fremont 60
Turin 48
Dong Ket 43
Boardman 41
Boston 40
Shanghai 36
Milan 34
San Diego 34
Nanjing 33
Helsinki 32
Hangzhou 29
Munich 29
Guangzhou 26
Ottawa 25
Toronto 24
Washington 23
Wuhan 22
New York 18
Norwalk 18
Zhengzhou 18
Brussels 17
Hefei 13
Phoenix 13
Pune 13
Siena 13
Jinan 12
Shenyang 12
Changsha 11
Falls Church 11
Rome 11
Verona 11
Bologna 10
Naples 10
Nürnberg 10
Tokyo 10
Leinì 9
Silver Spring 9
Chengdu 8
Fuzhou 8
Kunming 8
London 8
Monmouth Junction 8
Taipei 8
Buffalo 7
Central District 7
Copenhagen 7
Dallas 7
Nanchang 7
Nuremberg 7
Upper Marlboro 7
Xian 7
Cairo 6
Changchun 6
Florence 6
Hebei 6
Seoul 6
Toledo 6
Amman 5
Ardabil 5
Catania 5
Donetsk 5
Dresden 5
Hong Kong 5
Lachine 5
Memphis 5
Nashville 5
Nottingham 5
Paris 5
Rivoli 5
Tianjin 5
Ankara 4
Atripalda 4
Berlin 4
Carmagnola 4
Fort Lauderdale 4
Goianesia Do Para 4
Totale 6.983
Salva come PNG Salva come JPEG
Nome #
Quinone based nitric oxide donating compounds 508
H2S-Donating Doxorubicins May Overcome Cardiotoxicity and Multidrug Resistance 402
Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells 303
New furoxan derivatives for the treatment of ocular hypertension 273
Mitochondrial-targeting nitrooxy-doxorubicin: a new approach to overcome drug resistance. 262
Designing Multitarget Anti-inflammatory Agents: Chemical Modulation of the Lumiracoxib Structure toward Dual Thromboxane Antagonists-COX-2 Inhibitors. 262
Doxorubicin-antioxidant multitarget drugs 250
A Molecular Hybrid for Mitochondria-Targeted NO Photodelivery 197
(Nitrooxyacyloxy)methyl esters of aspirin as novel nitric oxide releasing aspirins 189
Galactosylated Pro-Drug of Ursodeoxycholic Acid: Design, Synthesis, Characterization, and Pharmacological Effects in a Rat Model of Estrogen-Induced Cholestasis 181
Synthesis and biological activity of furoxan derivatives against Mycobacterium tuberculosis 168
Synthesis physicochemical profile and PAMPA study of new NO-donor edaravone co-drugs 165
New nitric oxide or hydrogen sulfide releasing aspirins 164
Design, Synthesis, and Characterization of N-Oxide-Containing Heterocycles with in Vivo Sterilizing Antitubercular Activity 159
Development of a new class of potential antiatherosclerosis agents: NO-donor antioxidants 156
A Nonmetal-Containing Nitric Oxide Donor Activated with Single-Photon Green Light 156
Furazan and furoxan sulfonamides are strong α-carbonic anhydrase inhibitors and potential antiglaucoma agents 155
Synthesis and preliminary biological profile of new NO-donor tolbutamide analogues. 151
Combination of PDT and NOPDT with a tailored BODIPY derivative 149
Effects of Nitric Oxide Donor Antioxidants Containing the Phenol Vitamin E Substructure and a Furoxan Moiety on Ischemia/Riperfusion Injury 147
A rapid screening for cytochromes P450 catalysis on new chemical entities: cytochrome P450 BM3 and 1,2,5-oxadiazole derivatives 146
Anti-pseudomonas activity of 3-nitro-4-phenylfuroxan 144
Light-Tunable Generation of Singlet Oxygen and Nitric Oxide with a Bichromophoric Molecular Hybrid: a Bimodal Approach to Killing Cancer Cells 142
Novel nitro-oxy derivatives of celecoxib for the regulation of colon cancer cell growth 141
Nitrooxymethyl Substituted Analogues of Celecoxib: Synthesis and Pharmacological Characterization 140
gem-Dinitroalkyl Benzenes: A Novel Class of IOP-Lowering Agents for the Treatment of Ocular Hypertension 134
NO-donor COX-2 inhibitors. New nitrooxy-substituted 1,5-diarylimidazoles endowed with COX-2 inhibitory and vasodilator properties 131
A Potent and Selective P-gp Modulator for Altering Multidrug Resistance Due to Pump Overexpression 129
Synthesis and biological evaluation of the first example of NO-donor histone deacetylase inhibitor 127
Searching for new NO-donor aspirin-like molecules: furoxanylacyl derivatives of salicylic acid and related furazans 127
Searching for new NO-donor Aspirin-like molecules: a new class of nitrooxy-acyl derivatives of salicylic acid 125
Synthesis and preliminary pharmacological characterisation of a new class of nitrogen-containing bisphosphonates (N-BPs) 125
Water-Soluble Nitric-Oxide-Releasing Acetylsalicylic Acid (ASA) Prodrugs 125
A Nitric Oxide-Donor Furoxan Moiety Improves the Efficacy of Edaravone against Early Renal Dysfunction and Injury Evoked by Ischemia/Reperfusion 123
Amphiphilic NO-Donor Antioxidants 123
Fluorescent Nitric Oxide Photodonors Based on BODIPY and Rhodamine Antennae 119
NO-Donor Melatonin Derivatives: Synthesis And In Vitro Pharmacological Characterization 116
Nitric Oxide Donor Doxorubicins Accumulate into Doxorubicin-Resistant Human Colon Cancer Cells Inducing Cytotoxicity 116
Novel Antioxidant Agents Deriving From Molecular Combination of Vitamin C and NO-donor moieties 114
Multitarget Drugs: Focus on the NO-donor hybrid drugs 114
Structural and biological characterization of new hybrid drugs joining an HDAC inhibitor to different NO-donors 113
Synthesis of Some Novel Organic Nitrates and Comparative in Vitro Study of Their Vasodilator Profile 109
Design, Biological Evaluation, and Molecular Modeling of Tetrahydroisoquinoline Derivatives: Discovery of A Potent P-Glycoprotein Ligand Overcoming Multidrug Resistance in Cancer Stem Cells 108
A molecular hybrid producing simultaneously singlet oxygen and nitric oxide by single photon excitation with green light 107
NO-Donor Phenols: A New Class of Products Endowed with Antioxidant and Vasodilator Properties 102
Aceclofenac-galactose conjugate: design, synthesis, characterization and pharmacological and toxicological evaluations 101
Methotrexate-Loaded Solid Lipid Nanoparticles: Protein Functionalization to Improve Brain Biodistribution 98
Paracetamol-Galactose Conjugate: A Novel Prodrug for an Old Analgesic Drug 98
Mitochondrial delivery of phenol substructure triggers mitochondrial depolarization and apoptosis of cancer cells 97
Tuning the Hydrophobicity of a Mitochondria-Targeted NO Photodonor 96
A novel hybrid aspirin-NO releasing compound inhibits TNFalpha release from LPS-activated human monocytes and macrophages 96
A new class of ibuprofen derivatives with reduced gastrotoxicity 95
Different multitarget approaches to manage coxibs associatedcardiovascular risk. Design and synthesis of new lumiracoxibderivatives 94
Mechanistic insights into cyclooxygenase irreversible inactivation byaspirin 90
DNA-targeted NO release photoregulated by green light 90
EFFICIENTLY TARGETING DRUG EFFLUX THROUGH MODULATION OF P-GLYCOPROTEIN ACTIVITY BY SMALL MOLECULES: DESIGN, BIOLOGICAL AND COMPUTATIONAL STUDY. 87
Nitrooxyacyl Derivatives of Salicylic Acid: Aspirin-Like Molecules that Covalently Inactivate Cyclooxygenase-1 84
Synthesis and antimalarial activities of some furoxan sulfones and related furazans 79
NO-Donor Furoxans Containing a Sulphonamide Moiety and Related Furazans as Potent Carbonic Anhydrase Inhibitors 78
Amphiphile NO-donor antioxidants as polivalent drugs 76
Nitrooxy-doxorubicin: A New Weapon Against Multidrug Resistance. 74
A NEW CLASS OF BISPHOSPHONATES WITH NO-DONOR PROPERTIES 71
Antiinflammatory, gastrosparing, and antiplatelet properties of new NO-donor esters of aspirin 70
GIFC-2018 - BOOK OF ABSTRACTS 70
Novel water soluble furoxan derivatives having antitumor activity 69
Novel amphiphilic nitric oxide releasing antioxidants: NMR spectroscopic study of their interaction with biomembrane models 65
NO-Donor Cyanines As Potential Anti-Alzheimer Drugs 64
Can we exploit β-lactamases intrinsic dynamics for designing more effective inhibitors? 64
Nitrooxymethyl substituted analogues of celecoxib as potential antitumoral drugs with reduced cardiotoxicity 61
Salicilic acid derivatives 59
Furoxan nitric oxide donors disperse Pseudomonas aeruginosa biofilms, accelerate growth, and repress pyoverdine production 57
New class of NO-donor soluble aspirins 56
NOVEL SEMISYNTHETIC DOXORUBICINS WITH REDUCED CARDIOTOXICITY 54
NO donor - melatonins: a new class of potential antiatherosclerosis agents 53
Nitrooxymethyl substituted analogues of Celecoxib and Rofecoxib 52
Synthesis of NO-Donor Bisphosphonates and Their in Vitro Action on Bone Resorption 51
nitric oxide furoxan derivative compounds endowed with antitumoral activity 51
New NO-donor Bisphosphonates 48
NEW CLASS OF NO-DONORS WITH BONE SELECTIVITY 48
Synthesis, chiral HPLC resolution and configuration assignment of 1-phenylglyceryl trinitrate stereomers 48
New No-donor aspirin derivatives 46
Structure-Antioxidant Activity Relationships in a Series of NO-Donor Phenols 45
Enhancing doxorubicin anticancer activity with a novel polymeric platform photoreleasing nitric oxide 44
Studies of the potential genotoxic effects of furoxans: the case of CAS 1609 and of the water soluble analogue of CHF 2363 42
BROAD SPECTRUM METALLO beta-LACTAMASES INHIBITORS: NEW TOOLS AGAINST CLINICALLY-RELEVANT CARBAPENEMASES 41
Physicochemical profile and in vitro permeation behavior of a new class of non-steroidal anti-inflammatory drug candidates 40
The Furoxan System: Design of Selective Nitric Oxide (NO) Donor Inhibitors of COX-2 Endowed with Anti-Aggregatory and Vasodilating Activities 39
Structure-Activity Relationship Studies on Tetrahydroisoquinoline Derivatives: [4′-(6,7-Dimethoxy-3,4-dihydro-1H-isoquinolin-2-ylmethyl)biphenyl-4-ol] (MC70) Conjugated through Flexible Alkyl Chains with Furazan Moieties Gives Rise to Potent and Selective Ligands of P-glycoprotein 38
Michael addition of Grignard reagents to tetraethyl ethenylidenebisphosphonate 37
A generator of peroxynitrite activatable with red light 36
Tuning NO release of organelle-targeted furoxan derivatives and their cytotoxicity against lung cancer cells 34
NO-donor aspirin derivatives 32
Farmaci antiinfiammatori non steroidei 32
Comparative Study of Different H2S Donors as Vasodilators and Attenuators of Superoxide-Induced Endothelial Damage 31
Cryo-EM structures of staphylococcal IsdB bound to human hemoglobin reveal the process of heme extraction 27
NO release regulated by doxorubicin as the green light-harvesting antenna 26
Multitarget antioxidant NO-donor organic nitrates: a novel ap-proach to overcome nitrates tolerance, an ex vivo study 22
Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors 18
Cryo-EM undiscloses structural and mechanistic details on iron hijacking by Staphylococcus aureus: An insight into the interaction of IsdB hemophore with human hemoglobin 13
Surface Functionalised Parenteral Nanoemulsions for Active and Homotypic Targeting to Melanoma 12
Totale 10.696
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.377
article - articoli 0
book - libri 0
conference - conferenze 3.464
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.841
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.909 68 64 120 235 130 237 202 160 223 207 150 113
2020/20211.314 120 99 88 82 118 82 82 92 174 133 72 172
2021/20221.634 134 91 113 149 91 57 116 107 76 91 349 260
2022/20231.822 173 173 54 160 148 433 229 93 170 71 75 43
2023/20241.046 111 140 64 66 88 173 42 57 21 75 83 126
2024/202553 53 0 0 0 0 0 0 0 0 0 0 0
Totale 10.752